MedTech Associations Recognize Sen. Hatch for Leadership in MedTech Innovation

The Advanced Medical Technology Association and BioUtah presented Sen. Orrin Hatch (R-Utah) an award for his leadership in supporting and advancing medical technology innovation and patient access to care in the United States.

Hatch was the lead author of legislation to suspend the medical device tax, which forced medical device companies to reduce hiring, slow capital expansion, and lower funding for research and development when it went into effect in 2013. His leadership in securing a two-year suspension of the tax last year has paved the way for the medical technology industry to reinvest in R&D, infrastructure, workforce expansion and innovation to benefit patients.

“Sen. Hatch has worked tirelessly to ensure that medical technology companies can continue to innovate tomorrow’s medical miracles,” said Scott Whitaker, president and CEO of AdvaMed. “I applaud his leadership in ensuring that America’s clinicians and patients have access to cutting-edge medical technologies.”

“BioUtah and its members value Sen. Hatch’s leadership and hard work driving key policies that promote medical innovation. The two-year suspension of the medical device tax has benefited Utah medical device companies by allowing them to recapture critical revenue and reinvest it into R&D, new product development and expand hiring, which will contribute to continued growth in Utah’s economy,” said Kelly Slone, president and CEO, BioUtah.    

“Patient access to medical technology holds tremendous potential to improve health and to reduce costs. The policies Sen. Hatch has championed will help ensure clinicians and patients have access to the most cutting-edge technologies and treatments that lead to lower costs, faster recovery times, healthier patients, and improved overall quality of life – especially for patients with chronic conditions,” said Whitaker.

Sen. Hatch serves on the Senate Finance and Health, Education, Labor and Pensions (HELP) Committees. The United States has long been the worldwide leader in medical technology innovation, and Sen. Hatch’s work has been critical in ensuring that we retain our leadership and can continue to improve patient care.